ISOPP 2019 Interview: Biosimilars in Pharmacy Practice: Trastuzumab, Rituximab and Beyond
Year:
2019
Type:
Video
Source:
ISOPP
Authors/Presenters:
Rob Duncombe

Biosimilars can bring many benefits; here, Rob Duncombe, of the Christie NHS Foundation Trust, Manchester, UK, discusses the biosimilars currently being used in cancer treatment, and the key role of pharmacists in their implementation and usage. This interview took place at the International Society of Oncology Pharmacy Practitioners (ISOPP) Symposium 2019, hosted by the British Oncology Pharmacy Association (BOPA), held in London, UK.

Last updated:
January 9, 2025

Authors/Presenters

Rob Duncombe
Rob Duncombe
Chief Pharmacist
The Royal Marsden Hospital
United Kingdom
Photo of Rob Duncombe
Photo of Rob Duncombe
Rob Duncombe
Chief Pharmacist — The Royal Marsden Hospital
United Kingdom

Would you like to learn more about this member/person? Unlock exclusive insights and content by logging in or signing up for a no-cost membership account today. Join our community to explore further.

Join ISOPP Today!Member Login
More Info

Related Events

International Symposium
-
Novotel London West, London, UK
In recent years we have seen an explosion in new technology and novel drug therapies. In our quest to keep up with new developments it can be easy to lose sight of what is most important – providing high quality pharmaceutical care for our patients. How can we deliver a modern oncology pharmacy service with a human touch?